Fatty liver treatment of fatty liver capsule clinical observation.docVIP

Fatty liver treatment of fatty liver capsule clinical observation.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Fatty liver treatment of fatty liver capsule clinical observation

 PAGE \* MERGEFORMAT 7 Fatty liver treatment of fatty liver capsule clinical observation Of: Haihua, Zhang Yu, Zhang Fengyun guide: Platinum yet [Keywords:] fatty liver capsule, fatty liver, Chinese medicine Fatty liver is the liver itself and extrahepatic causes excessive deposition of fat in the liver caused by a common disease lasting. Although most of the fatty liver a good prognosis, but there is still some inflammation, especially associated with the development of fatty liver is likely to continue into liver fibrosis and cirrhosis. Therefore, prevention and treatment of fatty liver has very important clinical significance. hospital gastroenterology self-made fatty liver treatment of fatty liver capsule to achieve better efficacy, are reported below. 1 General Information Cases observed from September 2006 -2009 outpatients in December, the clinical diagnosis and pathological diagnosis are in line with the Chinese Medical Association 2002 Institute of fatty liver and liver disease alcoholic liver disease study group developed the diagnostic criteria [1]. By Random sampling the patients were divided into 2 groups. the treatment group 70 cases, 53 males and 17 females, aged 28 to 66 years, mean age (41.5 + -11.2 years), duration of 2 to 38 months, average duration (16.6 + -5.2 ) months. the control group of 50 patients, 31 males and 19 females, aged 29 to 61 years, mean age (42.6 + -12.4 years), duration of 1 to 46 months, average duration (18.5 + -6.3) .2 months group sex, age, duration, etc. The difference was not statistically significant (Pgt; 0.05), comparable. 2 treatment Treatment group to the fatty liver capsule (from Bupleurum, Alisma, Poria, Citrus, Cassia, evening primrose, bear bile powder, Corydalis, hawthorn, Salvia, fleece-flower root, Chinese yam, licorice component, hospital preparation room provided) , 2 capsules, 3 times a day. control group was treated dongbaogantai (Tonghua Toho Pharmaceutical Co., Ltd. Producti

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档